New York State Common Retirement Fund’s Neuropace NPCE Stock Holding History

New York State Common Retirement Fund’s Portfolio NPCE Stock Details NPCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$122K	Hold	7,700	–	–	﹤0.01%	2585
2026 Q1	$101K	Hold	7,700	–	–	﹤0.01%	2518
2025 Q4	$119K	Buy	7,700 +6,800	+756%	+$90.9K	﹤0.01%	2529
2025 Q3	$9.28K	Hold	900	–	–	﹤0.01%	3159
2025 Q2	$10K	Hold	900	–	–	﹤0.01%	3160
2025 Q1	$11.1K	Hold	900	–	–	﹤0.01%	3067
2024 Q4	$10.1K	Hold	900	–	–	﹤0.01%	3113
2024 Q3	$6.27K	Sell	900 -13,400	-94%	-$98K	﹤0.01%	3134
2024 Q2	$108K	Buy	+14,300	New	+$144K	﹤0.01%	2716
2022 Q3	–	Sell	-66	Closed	–	–	3396
2022 Q2	$0	Sell	66 -6,000	-99%	-$39.6K	﹤0.01%	3519
2022 Q1	$50K	Hold	6,066	–	–	﹤0.01%	3169
2021 Q4	$61K	Hold	6,066	–	–	﹤0.01%	3188
2021 Q3	$96K	Buy	6,066 +66	+1%	+$1.39K	﹤0.01%	3153
2021 Q2	$143K	Buy	+6,000	New	+$139K	﹤0.01%	3142

Other funds holding NPCE

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

New York State Common Retirement Fund's NPCE Position: Q2 2026 in Review

New York State Common Retirement Fund held its Neuropace (NPCE) position steady in Q2 2026 at 7,700 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #2585.

New York State Common Retirement Fund first reported a position in NPCE in Q2 2021 and has held it in 14 quarters since. The position peaked at $143K in Q2 2021. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

New York State Common Retirement Fund held 7,700 shares of Neuropace worth $122K as of Q2 2026.
New York State Common Retirement Fund left its Neuropace share count unchanged in Q2 2026.
Neuropace made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2585 holding.
New York State Common Retirement Fund first reported a position in Neuropace in Q2 2021 and has held it in 14 quarters since.
New York State Common Retirement Fund's Neuropace position peaked at $143K in Q2 2021.
113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.